gaetana sterrantino
gaetana sterrantino
Verified email at
Cited by
Cited by
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals
A Azzi, R De Santis, S Ciappi, F Leoncini, G Sterrantino, N Marino, ...
Journal of neurovirology 2 (6), 411-416, 1996
Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART
G Guaraldi, R Murri, G Orlando, E Orlandi, G Sterrantino, M Borderi, ...
HIV Clinical Trials 4 (2), 99-106, 2003
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group
V Svicher, R D'Arrigo, C Alteri, M Andreoni, G Angarano, A Antinori, ...
Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
G Sterrantino, L Santoro, D Bartolozzi, M Trotta, M Zaccarelli
Patient preference and adherence 6, 427, 2012
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid.
S Ciappi, A Azzi, R De Santis, F Leoncini, G Sterrantino, F Mazzotta, ...
Journal of general virology 80 (4), 1017-1023, 1999
Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR
G Al-Bakkal, G Ficarra, K McNeill, LR Eversole, G Sterrantino, C Birek
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 1999
Switch to dolutegravir plus rilpivirine dual therapy in cART-experienced subjects: an observational cohort
AF Capetti, G Sterrantino, MV Cossu, GC Orofino, G Barbarini, ...
PLoS One 11 (10), e0164753, 2016
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
AF Capetti, MV Cossu, G Orofino, G Sterrantino, G Cenderello, ...
BMC infectious diseases 17 (1), 1-7, 2017
Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin.
D Dionisio, A Orsi, G Sterrantino, M Meli, S Di Lollo, LI Manneschi, ...
Journal of clinical pathology 51 (2), 138-142, 1998
Aortic connective tissue in ageing—a biochemical study
L Andreotti, A Bussotti, D Cammelli, F Di Giovine, S Sampognaro, ...
Angiology 36 (12), 872-879, 1985
Sex between men in the context of HIV: The AIDS 2008 Jonathan Mann Memorial Lecture in health and human rights
J Saavedra, JA Izazola-Licea, C Beyrer
Journal of the International AIDS Society 11 (1), 9, 2008
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group
C Alteri, M Montano, R D'Arrigo, M Andreoni, G Angarano, A Antinori, ...
Edizioni Internazionali 35 (1), 17-25, 2012
Efficacy and tolerability of dolutegravir and two nucleos (t) ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients
A Borghetti, G Baldin, A Capetti, G Sterrantino, S Rusconi, A Latini, ...
Aids 31 (3), 457-459, 2017
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients: 96-week data
AF Capetti, MV Cossu, G Sterrantino, G Barbarini, S Di Giambenedetto, ...
Annals of Pharmacotherapy 52 (8), 740-746, 2018
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication
A Borghetti, G Baldin, F Lombardi, A Ciccullo, A Capetti, S Rusconi, ...
HIV medicine 19 (7), 452-454, 2018
Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone.
D Dionisio, LI Manneschi, S Di Lollo, A Orsi, G Sterrantino, M Meli, ...
Journal of clinical pathology 50 (6), 472-476, 1997
Timed short messaging service improves adherence and virological outcomes in HIV-1–infected patients with suboptimal adherence to antiretroviral therapy
A Ammassari, MP Trotta, N Shalev, MC Tettoni, S Maschi, F Di Sora, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (4), e113-e115, 2011
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience
A Capetti, S Landonio, P Meraviglia, A Di Biagio, SL Caputo, ...
PLoS One 7 (7), e39222, 2012
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis
G Sterrantino, M Zaccarelli, G Colao, F Baldanti, S Di Giambenedetto, ...
Infection 40 (3), 311-318, 2012
Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.
D Dionisio, LI Manneschi, S Di Lollo, A Orsi, G Sterrantino, F Leoncini, ...
Journal of clinical pathology 51 (10), 731-736, 1998
The system can't perform the operation now. Try again later.
Articles 1–20